Plasma Apheresis Systems Market Size, Share, Growth, and Industry Analysis, By Type (Desktop Type, Trolley Type), By Application (Hospitals, Blood Centers, Others), Regional Insights and Forecast to 2035

Plasma Apheresis Systems Market Overview

The Plasma Apheresis Systems Market size valued at USD 401.53 million in 2026 and is expected to reach USD 549.01 million by 2035, growing at a CAGR of 3.2% from 2026 to 2035.

The Plasma Apheresis Systems Market is witnessing strong expansion due to increasing plasma collection activities, rising autoimmune disorder cases, and growing demand for plasma-derived therapies. More than 65 million liters of plasma were collected globally in 2024, with over 58% used for immunoglobulin production. Plasma Apheresis Systems Market Analysis indicates that automated plasma collection devices account for nearly 72% of total installations worldwide. The Plasma Apheresis Systems Industry Report highlights that over 9,500 plasma collection centers operated globally in 2024, compared with 7,800 facilities in 2020. Portable plasma apheresis devices represented 31% of new installations during 2024, supporting higher procedural efficiency and donor throughput.

The USA dominates the Plasma Apheresis Systems Market Share with more than 1,050 operational plasma donation centers in 2024. The country accounted for approximately 69% of global source plasma supply, according to Plasma Apheresis Systems Market Research Report data. More than 53 million plasma donations were recorded in the United States during 2024, increasing by 11% compared to 2022 levels. The Plasma Apheresis Systems Market Outlook in the USA remains favorable because over 42 million citizens suffer from chronic diseases requiring plasma-derived medicines. Hospitals across 48 states adopted automated apheresis systems with digital monitoring capabilities, while over 76% of blood centers upgraded centrifugation-based plasma extraction platforms.

Key Findings

• Key Market Driver: 68% demand increase linked to autoimmune therapies, 61% rise in plasma-derived medicine utilization, 57% growth in neurological disorder treatment procedures, and 49% expansion in plasma donation infrastructure across major healthcare economies.
• Major Market Restraint: 43% of healthcare facilities report high equipment maintenance concerns, 39% face skilled operator shortages, 34% cite disposable kit dependency, and 29% of smaller clinics delay installations due to regulatory complexity.
• Emerging Trends: 74% adoption of automated monitoring systems, 58% integration of AI-supported donor screening, 46% increase in portable plasma apheresis devices, and 41% rise in cloud-connected plasma management software installations globally.
• Regional Leadership: North America holds 47% market share, Europe accounts for 24%, Asia-Pacific captures 22%, while Middle East & Africa contribute 7% of Plasma Apheresis Systems Market Size globally.
• Competitive Landscape: Top 5 manufacturers control approximately 63% of global supply, while automated device manufacturers account for 71% of hospital procurement contracts and 54% of blood center equipment modernization projects.
• Market Segmentation: Desktop systems contribute 59% of installations, trolley-type systems hold 41%, hospitals account for 52% application demand, blood centers represent 37%, and other healthcare facilities contribute 11%.
• Recent Development: Between 2023 and 2025, 44% of manufacturers introduced digital interface upgrades, 36% launched portable systems, 31% expanded plasma throughput capacity, and 27% improved donor safety monitoring technologies.

Plasma Apheresis Systems Market Latest Trends

The Plasma Apheresis Systems Market Trends indicate rapid adoption of automated and digitalized plasma collection technologies across healthcare systems. In 2024, nearly 74% of newly installed plasma apheresis systems included touchscreen interfaces and automated flow regulation. Plasma Apheresis Systems Market Insights reveal that collection efficiency improved by 22% in facilities implementing AI-assisted donor monitoring systems. More than 61% of plasma collection centers upgraded to closed-loop disposable tubing systems to reduce contamination risks and improve donor safety.

The Plasma Apheresis Systems Market Forecast highlights strong demand for portable and trolley-mounted devices, which represented 41% of all new procurement contracts during 2024. Battery-powered systems capable of operating for 6 to 8 hours without external electricity gained popularity in emergency healthcare applications. Plasma Apheresis Systems Industry Analysis also shows that dual-needle collection systems accounted for 67% of installations due to shorter collection times averaging 35 minutes per donor session.

Healthcare providers increased adoption of cloud-connected plasma monitoring software by 46% between 2022 and 2024. More than 33% of hospitals integrated plasma collection data with electronic health records. The Plasma Apheresis Systems Market Opportunities are also expanding through rising demand for immunoglobulin therapies, which increased plasma extraction procedures by 18% globally during 2024.

Plasma Apheresis Systems Market Dynamics

DRIVER:

"Rising demand for plasma-derived therapies"

The Plasma Apheresis Systems Market Growth is strongly supported by increasing utilization of plasma-derived medicinal products. More than 430,000 patients globally receive immunoglobulin therapies annually, while plasma-derived albumin usage increased by 17% between 2021 and 2024. Plasma Apheresis Systems Market Research Report findings show that neurological disorders affected over 1 billion people globally in 2024, increasing demand for therapeutic plasma exchange procedures. Hospitals conducting more than 1,500 plasma separation procedures annually increased by 28% over the past 3 years. Automated plasma collection systems reduced donor processing time by nearly 19 minutes per session, improving operational productivity by 34%. Healthcare systems in 39 countries expanded plasma donation infrastructure during 2023 and 2024, significantly increasing equipment procurement activities.

RESTRAINT:

"High equipment and maintenance complexity"

The Plasma Apheresis Systems Industry Report identifies maintenance complexity as a major limitation affecting smaller healthcare facilities. Approximately 43% of regional blood centers reported operational disruptions caused by equipment calibration requirements. Disposable tubing kits contribute nearly 32% of operational costs associated with plasma collection procedures. More than 29% of hospitals in developing economies delayed equipment modernization because of technician shortages and complex regulatory approvals. Plasma Apheresis Systems Market Analysis indicates that device sterilization protocols increased operational downtime by 14% in medium-sized collection centers. Additionally, replacement cycles for centrifugal components average 3 to 5 years, creating procurement burdens for facilities operating below 200 monthly plasma procedures.

OPPORTUNITY:

" Expansion of plasma collection infrastructure"

The Plasma Apheresis Systems Market Opportunities continue expanding due to rising investments in plasma donation centers and blood collection networks. More than 680 new plasma collection centers were announced globally between 2023 and 2025. Asia-Pacific countries increased plasma infrastructure funding by 26%, supporting broader deployment of automated apheresis devices. Plasma Apheresis Systems Market Outlook data shows that emerging economies increased healthcare automation projects by 38% during 2024. Portable plasma apheresis systems suitable for mobile blood drives expanded by 31% in rural healthcare operations. Hospitals integrating AI-supported donor eligibility software reduced donor rejection rates by 12%, increasing collection efficiency. Additionally, demand for plasma-derived therapies for rare immune diseases rose by 24%, encouraging healthcare providers to invest in advanced plasma extraction technologies.

CHALLENGE:

"Regulatory and donor safety compliance"

The Plasma Apheresis Systems Market faces challenges associated with strict donor safety standards and regulatory compliance requirements. More than 37% of plasma collection facilities reported delays in system approvals due to changing medical device standards during 2024. Plasma donation centers must maintain donor monitoring accuracy above 98%, increasing calibration and validation burdens. Plasma Apheresis Systems Market Trends show that approximately 21% of healthcare facilities experienced interruptions due to disposable supply shortages. Furthermore, donor retention rates declined by 9% in regions with longer collection waiting periods exceeding 45 minutes. Device operators require specialized certification in over 28 countries, limiting workforce availability and slowing deployment of advanced plasma separation systems in developing healthcare markets.

Download FREE Sample to learn more about this report.

Segmentation Analysis

By Type

• Desktop Type: Desktop plasma apheresis systems accounted for nearly 59% of the Plasma Apheresis Systems Market Share in 2024. These systems are widely adopted in hospitals and blood centers handling between 20 and 80 plasma collection procedures daily. Desktop models occupy approximately 35% less floor space than trolley systems, making them suitable for compact healthcare facilities. Plasma Apheresis Systems Market Insights reveal that over 72% of urban hospitals preferred desktop devices due to lower maintenance requirements and simplified software integration. Modern desktop units process plasma extraction within 30 to 40 minutes while maintaining plasma purity levels above 96%. Approximately 48% of newly launched desktop devices include automated donor monitoring and digital touchscreen control systems.
• Trolley Type: Trolley-type plasma apheresis systems represented 41% of global installations in 2024. These systems are increasingly used in mobile blood collection campaigns and large-scale plasma donation centers processing over 150 donors daily. Plasma Apheresis Systems Market Trends indicate that trolley systems improved healthcare mobility efficiency by 29% during field operations. Battery-supported trolley devices provide operational continuity for 6 to 8 hours, supporting emergency and remote healthcare applications. More than 44% of plasma collection facilities in Asia-Pacific adopted trolley-mounted systems because of flexible movement and faster donor handling capabilities. Advanced trolley systems include integrated centrifugation modules with processing capacities exceeding 800 milliliters per session.

By Application

• Hospitals: Hospitals accounted for approximately 52% of Plasma Apheresis Systems Market Size during 2024. More than 18,000 hospitals globally perform therapeutic plasma exchange procedures for neurological and autoimmune conditions. Plasma Apheresis Systems Market Analysis shows that tertiary hospitals conduct an average of 1,200 plasma procedures annually. Nearly 64% of hospital installations involve automated dual-needle systems that reduce collection time by 15% compared with single-needle devices. Hospitals in North America increased plasma therapy departments by 21% during the last 3 years. Digital integration with hospital management systems improved patient monitoring accuracy by 27%, further supporting adoption of advanced plasma apheresis systems in critical care applications.
• Blood Centers: Blood centers contributed nearly 37% of the Plasma Apheresis Systems Market Share in 2024. More than 9,500 plasma collection centers worldwide utilize automated plasma extraction systems. Blood centers handling over 50,000 annual donations increased equipment modernization spending by 32% between 2022 and 2024. Plasma Apheresis Systems Market Research Report findings indicate that donor throughput improved by 24% after implementing automated plasma collection devices. More than 58% of blood centers adopted closed-loop disposable systems to reduce contamination risk and improve plasma quality. Asia-Pacific blood banks increased plasma collection campaigns by 19% during 2024, contributing significantly to system demand.
• Others: Other applications, including specialty clinics and research institutions, represented 11% of the Plasma Apheresis Systems Market Outlook in 2024. Research facilities increased plasma extraction procedures by 14% for immunotherapy and regenerative medicine studies. Specialty clinics focusing on autoimmune disease treatment adopted compact plasma apheresis systems with treatment capacities ranging from 400 to 700 milliliters per cycle. Approximately 33% of university hospitals conducting plasma research integrated AI-supported donor analysis software into apheresis workflows. Portable systems accounted for 26% of installations in research laboratories because of flexibility and lower infrastructure requirements. Increasing clinical trials involving plasma therapies continue supporting demand in this segment.

Download FREE Sample to learn more about this report.

Regional Outlook

North America

North America dominated the Plasma Apheresis Systems Market with approximately 47% share during 2024. The region operated more than 1,350 plasma collection centers, with the United States contributing nearly 78% of regional plasma donations. Plasma Apheresis Systems Market Growth in North America is supported by increasing prevalence of autoimmune diseases affecting over 50 million individuals. More than 61% of hospitals in the region integrated automated donor screening software into plasma collection operations. Canada expanded plasma collection capacity by 18% between 2022 and 2024 through modernization of blood donation infrastructure. Plasma-derived therapy demand increased by 23% across North America, driving installations of advanced centrifugal plasma extraction systems. Nearly 69% of regional facilities adopted dual-needle plasma collection technology to reduce donor session duration.

Europe

Europe represented approximately 24% of the Plasma Apheresis Systems Market Share in 2024. Germany, France, Italy, and the United Kingdom accounted for more than 63% of regional plasma collection procedures. Plasma Apheresis Systems Industry Analysis indicates that over 420 plasma donation centers operated across Europe during 2024. Automated plasma collection systems accounted for 66% of hospital procurement contracts in the region. European healthcare facilities increased therapeutic plasma exchange procedures by 16% between 2021 and 2024. Portable plasma systems witnessed 28% installation growth in rural healthcare operations. More than 54% of plasma collection centers upgraded to digitally integrated donor management platforms. Regulatory focus on donor safety increased adoption of closed-loop sterile collection technologies across regional blood centers.

Asia-Pacific

Asia-Pacific accounted for nearly 22% of the Plasma Apheresis Systems Market Size in 2024. China, Japan, South Korea, and India represented over 71% of regional demand for plasma collection systems. Plasma Apheresis Systems Market Forecast data shows that healthcare infrastructure investments increased by 34% across Asia-Pacific during 2023 and 2024. China expanded plasma donation capacity through the addition of over 120 new collection facilities. Japan increased therapeutic plasma exchange procedures by 13% because of rising elderly population needs. India witnessed 29% growth in plasma collection modernization projects across metropolitan hospitals. More than 46% of new installations in Asia-Pacific involved trolley-mounted plasma apheresis systems supporting flexible healthcare delivery models. Regional blood centers also improved donor throughput by 22% using automated plasma extraction technologies.

Middle East & Africa

Middle East & Africa held approximately 7% of the Plasma Apheresis Systems Market Outlook during 2024. Gulf countries represented over 58% of regional installations because of healthcare modernization initiatives. Plasma Apheresis Systems Market Insights indicate that plasma collection procedures increased by 17% across the Middle East between 2022 and 2024. Saudi Arabia and the UAE expanded blood donation programs by nearly 21%, increasing demand for automated collection systems. Africa witnessed growing investment in blood safety infrastructure, with over 90 new plasma collection units deployed in urban hospitals. Portable trolley-type systems represented 39% of regional installations because of operational flexibility in remote healthcare facilities. Increasing awareness regarding plasma-derived therapies continues supporting adoption across the region.

List of Top Plasma Apheresis Systems Companies

• Terumo BCT
• Fresenius Kabi
• Haemonetics
• Asahi Kasei Medical
• Nikkiso
• Braun
• Miltenyi Biotec
• Kaneka Medix
• Nigale
• Haier Biomedical
• Scinomed
• Medica SPA
• Dahua Medical Instrument

Top two companies with highest market share:

• Terumo BCT holds approximately 24% market share with installations across more than 90 countries and over 6,000 active plasma collection systems globally.
• Fresenius Kabi accounts for nearly 19% market share with plasma processing technologies utilized in more than 3,500 healthcare facilities worldwide.

Investment Analysis and Opportunities

The Plasma Apheresis Systems Market Opportunities are expanding through healthcare automation investments and increasing plasma donation infrastructure. More than 680 plasma collection facilities were announced globally between 2023 and 2025. Healthcare organizations increased capital allocation toward automated plasma systems by 31% during 2024. Plasma Apheresis Systems Market Research Report findings indicate that AI-supported donor management platforms improved donor retention rates by 14%. Asia-Pacific countries expanded blood safety and plasma processing budgets by 26%, encouraging procurement of digital plasma collection systems.

Portable plasma apheresis systems attracted significant investment due to operational flexibility and lower infrastructure requirements. Approximately 41% of healthcare modernization projects included mobile plasma collection capabilities. Plasma Apheresis Systems Market Insights reveal that dual-needle systems improved collection efficiency by 27%, making them attractive for high-volume blood centers. Research institutions increased spending on plasma-based immunotherapy studies by 18% during 2024. Opportunities are also growing in rural healthcare outreach programs, where portable trolley systems reduced setup time by 33%. Hospitals implementing automated plasma monitoring software improved treatment workflow accuracy by 24%, encouraging broader adoption of advanced apheresis technologies.

New Product Development

The Plasma Apheresis Systems Market Trends reflect continuous innovation in automated plasma collection and donor monitoring technologies. Between 2023 and 2025, approximately 44% of manufacturers launched systems with touchscreen interfaces and cloud-connected monitoring functions. New plasma apheresis devices reduced procedure duration from 50 minutes to nearly 34 minutes per session. Plasma Apheresis Systems Market Analysis indicates that advanced centrifugation modules improved plasma separation purity above 97%.

Manufacturers introduced compact desktop systems with weight reductions of 18% compared to previous models. More than 36% of newly released systems included wireless data transfer capabilities supporting integration with hospital information systems. Portable trolley devices with lithium battery support expanded operational continuity to 8 hours. Plasma Apheresis Systems Market Outlook also highlights innovations in disposable sterile tubing kits, reducing contamination risks by 21%. AI-powered donor screening platforms improved donor eligibility accuracy above 95%, reducing operational delays. Companies additionally introduced low-noise plasma pumps operating below 55 decibels, improving donor comfort during collection procedures. Enhanced digital diagnostics reduced maintenance downtime by approximately 16%.

Five Recent Developments (2023-2025)

1. In 2024, Terumo BCT launched an upgraded automated plasma collection system with 22% faster donor processing and touchscreen-enabled monitoring capabilities.
2. Fresenius Kabi expanded plasma collection equipment production capacity by 18% in 2023 to meet rising hospital demand across Europe and North America.
3. Haemonetics introduced AI-assisted donor screening software in 2025, improving donor eligibility assessment accuracy above 95%.
4. Asahi Kasei Medical developed a portable trolley-based plasma apheresis device in 2024 capable of operating continuously for 8 hours on battery power.
5. Braun implemented cloud-connected plasma monitoring integration across its advanced apheresis systems in 2025, improving real-time data tracking efficiency by 29%.

Report Coverage of Plasma Apheresis Systems Market

The Plasma Apheresis Systems Market Report provides extensive coverage of market size, market share, technology trends, competitive landscape, and regional performance across North America, Europe, Asia-Pacific, and Middle East & Africa. The report evaluates more than 13 leading manufacturers and analyzes over 25 countries involved in plasma collection infrastructure development. Plasma Apheresis Systems Market Research Report coverage includes segmentation by type, application, healthcare facility size, and donor collection capacity.

The Plasma Apheresis Systems Industry Report examines installation trends for desktop and trolley-type systems, with automated systems representing over 71% of global procurement. The report also analyzes plasma donation center expansion, where more than 680 new facilities were announced between 2023 and 2025. Plasma Apheresis Systems Market Forecast studies include donor management software integration, portable collection technology, and AI-assisted monitoring platforms. The report further assesses hospital plasma therapy adoption rates, blood center modernization projects, disposable kit utilization, and therapeutic plasma exchange procedure volumes. Market coverage additionally includes regulatory frameworks, operational efficiency benchmarks, donor retention metrics, and technological advancements affecting global plasma collection infrastructure.